Fuso Pharmaceutical Industries,Ltd.
4538.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$18.04B
Close$
Share Statistics
| Market cap | $18.04 Billion |
|---|---|
| Enterprise Value | $39.78 Billion |
| Dividend Yield | $90.00 (4.26%) |
| Earnings per Share | $235.52 |
| Beta | 0.16 |
| Outstanding Shares | 8,536,588 |
Return
| Return on Equity | 6.13% |
|---|---|
| Return on Assets | 2.50% |
| Return on Invested Capital | 7.69% |
Valuation & Multiples
| P/E Ratio | 8.23 |
|---|---|
| PEG | 21.13 |
| Price to Sales | 0.29 |
| Price to Book Ratio | 0.5 |
| Enterprise Value to Revenue | 0.63 |
| Enterprise Value to EBIT | 13.16 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.66 |
| Debt to Equity | 0.74 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Fuso Pharmaceutical Industries,Ltd.
1,370 employees
CEO: Mikio Toda Fuso Pharmaceutical Industries, Ltd. is a Japanese firm primarily involved in the development and commercialization of pharmaceutical goods. Their product range encompasses prescription medications, particularly injectables and solutions...